DCGI Disapproves Administration Of Covaxin To Those Below 18 Yrs
New Delhi : In a major shift of narrative, the government has now disapproved the authorisation of Bharat Biotech’s Covid vaccine to people below 18 years of age whereas earlier, it…
India will have happy New Year with vaccine in hand: DCGI
The drug regulator is currently analysing the data submitted by Serum Institute of India, which is manufacturing Oxford-AstraZeneca vaccine and Bharat Biotech, which is making indigenous vaccine in collaboration with ICMR. The expert panel…
Zydus Cadila seeks approval to begin phase III trials of COVID-19 vaccine ZyCoV-D
Zydus Cadila, an innovation driven global pharmaceutical company focused on discovering and developing NCEs, novel biologicals, biosimilars and vaccines, announced that its plasmid DNA vaccine to prevent COVID-19, ZyCoV-D was…
Cipla Seeks Approval To Modify Remdesivir Composition To Reduce Renal Toxicity
Mumbai : The Mumbai headquartered pharma giant Cipla has sought approval from the subject expert committee (SEC) at the Central Drugs Standard Control Organisation (CDSCO) to modify Covid-19 drug remdesivir’s composition…
India likely to approve AstraZeneca vaccine by next week: Sources
NEW DELHI: India is likely to approve Oxford/AstraZeneca’s coronavirus vaccine for emergency use by next week after its local manufacturer submitted additional data sought by authorities, two sources with knowledge…
DCGI Seeking More Data For Granting Emergency Use Authorisation Won’t Impact Timeline For Vaccine Roll-Out: Govt
New Delhi : The applications of Bharat Biotech, Serum Institute and Pfizer seeking emergency use authorisation for their COVID-19 vaccines are being examined, the Centre said on Tuesday asserting that drug…
CDSCO To Identify And Set Up Two Additional Facilities For Testing COVID-19 Vaccines
New Delhi : To expedite and regulate the testing of COVID-19 vaccine, the Central Drugs Standard Control Organisation (CDSCO) is in the process of putting a functioning mechanism in place. The…
NPPA extends revised ceiling price of Heparin Injection till March 2021
The National Pharmaceutical Pricing Authority (NPPA) has extended the revised ceiling price of Heparin Injection 5000IU/ml and 1000 IU/ml up to March 2021. The authority has taken the decision based…
SLAs Ask Mask Manufacturers To Expeditiously Register With CDSCO For Compliance
Mumbai : While the central government had allowed mask manufacturers to manufacture and then apply for registration within 18 months considering the ongoing pandemic, the state licensing authorities (SLAs) have…
SEC Asks DCGI To Dig Out Details About ‘Side-Effects’ Of HCQ
New Delhi : The Narendra Modi government has recommended to the Central Drugs Standard Control Organisation (CDSCO), the country’s apex health regulatory body, to find out more details about the…
